4.5 Article

Combined fibroblast growth factor receptor 4 cell membrane chromatography online with high performance liquid chromatography/mass spectrometry to screen active compounds in Brassica albla

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.jchromb.2012.10.029

Keywords

Fibroblast growth factor receptor 4; Cell membrane chromatography; High performance liquid chromatography/mass spectrometry; Brassica albla L.; Sinapine

Funding

  1. National Natural Science Foundation of China [81202495]
  2. Program for New Century Excellent Talents in University [NCET-08-0437]
  3. Fundamental Research Funds for the Central University

Ask authors/readers for more resources

We investigated an analytical method for the recognition separation, and identification of active components from the traditional Chinese medicinal plant Brassica albla L. using fibroblast growth factor receptor 4 cell membrane chromatography (FGFR4/CMC) with high performance liquid chromatography/mass spectrometry (HPLC/MS). HEK293-FGFR4 cells were obtained by stable transfection of the HEK293 cell line with pcDNA3.1 vector containing the FGFR4 gene. Crude extracts of B. albla L. were firstly subjected to FGFR4/CMC column, and the retain contents on the FGFR4/CMC column were then transferred and enriched using a pre-column, and a ten port column switcher were used between FGFR4/CMC column and HPLC. The retained components on FGFR4/CMC column were then directly delivered to the HPLC/MS system for separation and identification. Gefitinib, nicotine, atenolol, and nimodipine were used in order to verify FGFR4/CMC-HPLC/MS system specificity. Subsequently, we investigated the reproducibility and reliability of the FGFR4/CMC-HPLC/MS system. Finally, sinapine was identified as an active component of B. albla L The MTT calorimetric assay revealed sinapine could inhibit the proliferation of HEK293-FGFR4 cells with dose dependence. Competitive displacement assay approved getitinib could occupy binding site of sinapine with competition way. And FleX dock simulation further exhibited sinapine and gefitinib could bind with the FGFR4 tyrosine active domain. Thus, sinapine is a potential tumor antagonist that acts on the tyrosine kinase domain. (C) 2012 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available